49 Matching Annotations
  1. Dec 2024
  2. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Preclinical Characterization of ARX517, a Site-Specific Stable PSMA-Targeted Antibody–Drug Conjugate for the Treatment of Metastatic Castration-Resistant Prostate Cancer
    1
    1. scibot 11 Dec 2024
      RRID:CVCL_4782

      DOI: 10.1158/1535-7163.MCT-23-0927

      Resource: (RRID:CVCL_4782)

      Curator: @scibot

      SciCrunch record: RRID:CVCL_4782

      What is this?
      RRID:CVCL_4782
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC11612621/
  3. Nov 2024
  4. www.sciencedirect.com www.sciencedirect.com
    Spatial transcriptomics identifies RBM39 as a gene associated with Gleason score progression in prostate cancer
    1
    1. scibot 24 Nov 2024
      CRL-3314

      DOI: 10.1016/j.isci.2024.111351

      Resource: (RRID:CVCL_4782)

      Curator: @vtello

      SciCrunch record: RRID:CVCL_4782

      What is this?
      RRID:CVCL_4782
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2589004224025768
  5. Sep 2024
  6. aacrjournals.org aacrjournals.org
    Squalene epoxidase metabolic dependency is a targetable vulnerability in castration-resistant prostate cancer
    2
    1. scibot 12 Sep 2024
      RRID:CVCL_4782

      DOI: 10.1158/0008-5472.CAN-21-3822

      Resource: (RRID:CVCL_4782)

      Curator: @scibot

      SciCrunch record: RRID:CVCL_4782

      What is this?
      RRID:CVCL_4782
    2. scibot 12 Sep 2024
      RRID:CVCL_4782

      DOI: 10.1158/0008-5472.CAN-21-3822

      Resource: (RRID:CVCL_4782)

      Curator: @scibot

      SciCrunch record: RRID:CVCL_4782

      What is this?
      RRID:CVCL_4782
    Visit annotations in context

    Tags

    Annotators

    URL

    aacrjournals.org/cancerres/article/82/17/3032/708286/Squalene-Epoxidase-Metabolic-Dependency-Is-a
  7. Aug 2024
  8. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Rational Design and Development of Selective BRD7 Bromodomain Inhibitors and Their Activity in Prostate Cancer
    1
    1. scibot 28 Aug 2024
      RRID:CVCL_4782

      DOI: 10.1021/acs.jmedchem.3c00671

      Resource: (RRID:CVCL_4782)

      Curator: @vtello

      SciCrunch record: RRID:CVCL_4782

      What is this?
      RRID:CVCL_4782
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC10641717/
  9. www.biorxiv.org www.biorxiv.org
    Dual inhibition of ATR and DNA-PKcs radiosensitizes ATM-mutant prostate cancer
    1
    1. scibot 20 Aug 2024
      C4-2

      DOI: 10.1101/2024.07.10.602941

      Resource: (RRID:CVCL_4782)

      Curator: @vtello

      SciCrunch record: RRID:CVCL_4782

      What is this?
      RRID:CVCL_4782
    Visit annotations in context

    Tags

    Annotators

    URL

    biorxiv.org/content/10.1101/2024.07.10.602941v2
  10. febs.onlinelibrary.wiley.com febs.onlinelibrary.wiley.com
    Assessments of prostate cancer cell functions highlight differences between a pan-PI3K/mTOR inhibitor, gedatolisib, and single-node inhibitors of the PI3K/AKT/mTOR pathway
    1
    1. scibot 18 Aug 2024
      RRID:CVCL_4782

      DOI: 10.1002/1878-0261.13703

      Resource: (RRID:CVCL_4782)

      Curator: @scibot

      SciCrunch record: RRID:CVCL_4782

      What is this?
      RRID:CVCL_4782
    Visit annotations in context

    Tags

    Annotators

    URL

    febs.onlinelibrary.wiley.com/doi/10.1002/1878-0261.13703
  11. www.cell.com www.cell.com
    Elevating PLK1 overcomes BETi resistance in prostate cancer via triggering BRD4 phosphorylation-dependent degradation in mitosis
    1
    1. scibot 13 Aug 2024
      CRL-3314

      DOI: 10.1016/j.celrep.2024.114431

      Resource: (RRID:CVCL_4782)

      Curator: @dhovakimyan1

      SciCrunch record: RRID:CVCL_4782

      What is this?
      RRID:CVCL_4782
    Visit annotations in context

    Tags

    Annotators

    URL

    cell.com/cell-reports/fulltext/S2211-1247(24)00760-5
  12. Apr 2024
  13. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Cancer-associated fibroblasts promote enzalutamide resistance and PD-L1 expression in prostate cancer through CCL5-CCR5 paracrine axis
    1
    1. scibot 23 Apr 2024
      Cat#CRL-3314

      DOI: 10.1016/j.isci.2024.109674

      Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)

      Curator: @evieth

      SciCrunch record: RRID:CVCL_4782

      What is this?
      RRID:CVCL_4782
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC11031830/
  14. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    PARP inhibitors suppress tumours via centrosome error-induced senescence independent of DNA damage response
    1
    1. scibot 20 Apr 2024
      RRID: CVCL_4782

      DOI: 10.1016/j.ebiom.2024.105129

      Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)

      Curator: @abever99

      SciCrunch record: RRID:CVCL_4782

      What is this?
      RRID:CVCL_4782
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC11052917/
  15. aacrjournals.org aacrjournals.org
    Adipose triglyceride lipase is a therapeutic target in advanced prostate cancer that promotes metabolic plasticity
    1
    1. scibot 19 Apr 2024
      RRID:CVCL_4782

      DOI: 10.1158/0008-5472.CAN-23-0555

      Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)

      Curator: @anisehay

      SciCrunch record: RRID:CVCL_4782

      What is this?
      RRID:CVCL_4782
    Visit annotations in context

    Tags

    Annotators

    URL

    aacrjournals.org/cancerres/article/84/5/703/734936/Adipose-Triglyceride-Lipase-Is-a-Therapeutic
  16. Feb 2024
  17. 52.53.155.43 52.53.155.43
    can-23-0555-html.html
    2
    1. scibot 23 Feb 2024
      RRID:CVCL_4782

      DOI: 10.1158/0008-5472.can-23-0555

      Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)

      Curator: @scibot

      SciCrunch record: RRID:CVCL_4782

      What is this?
      RRID:CVCL_4782
    2. scibot 23 Feb 2024
      RRID:CVCL_4782

      DOI: 10.1158/0008-5472.can-23-0555

      Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)

      Curator: @scibot

      SciCrunch record: RRID:CVCL_4782

      What is this?
      RRID:CVCL_4782
    Visit annotations in context

    Tags

    Annotators

    URL

    52.53.155.43/e8db3efafb8a8253e8641e16f59e9a4a6a668dad/can-23-0555-html.html
  18. Jan 2024
  19. www.sciencedirect.com www.sciencedirect.com
    UCHL1 is a potential molecular indicator and therapeutic target for neuroendocrine carcinomas
    1
    1. scibot 20 Jan 2024
      CRL-3314

      DOI: 10.1016/j.xcrm.2023.101381

      Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)

      Curator: @evieth

      SciCrunch record: RRID:CVCL_4782

      What is this?
      RRID:CVCL_4782
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2666379123006109
  20. Dec 2023
  21. www.sciencedirect.com www.sciencedirect.com
    AID-induced CXCL12 upregulation enhances castration-resistant prostate cancer cell metastasis by stabilizing β-catenin expression
    1
    1. scibot 21 Dec 2023
      ATCCCat#CRL-3314

      DOI: 10.1016/j.isci.2023.108523

      Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)

      Curator: @evieth

      SciCrunch record: RRID:CVCL_4782

      What is this?
      RRID:CVCL_4782
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2589004223026007
  22. Nov 2023
  23. www.sciencedirect.com www.sciencedirect.com
    PIM1 targeted degradation prevents the emergence of chemoresistance in prostate cancer
    2
    1. scibot 28 Nov 2023
      RRID:CVCL_4782

      DOI: 10.1016/j.chembiol.2023.10.023

      Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)

      Curator: @olekpark

      SciCrunch record: RRID:CVCL_4782

      What is this?
      RRID:CVCL_4782
    2. scibot 28 Nov 2023
      RRID:CVCL_4782

      DOI: 10.1016/j.chembiol.2023.10.023

      Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)

      Curator: @scibot

      SciCrunch record: RRID:CVCL_4782

      What is this?
      RRID:CVCL_4782
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2451945623003847
  24. Sep 2023
  25. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Mechanistic target of rapamycin (mTOR) regulates self-sustained quiescence, tumor indolence, and late clinical metastasis in a Beclin-1-dependent manner
    1
    1. scibot 22 Sep 2023
      RRID:CVCL_4782

      DOI: 10.1080/15384101.2022.2123187

      Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)

      Curator: @scibot

      SciCrunch record: RRID:CVCL_4782

      What is this?
      RRID:CVCL_4782
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9928463/
  26. Aug 2023
  27. 52.53.155.43 52.53.155.43
    FEBS Press
    1
    1. scibot 03 Aug 2023
      RRID:CVCL_4782

      DOI: 10.1002/1878-0261.13484

      Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)

      Curator: @scibot

      SciCrunch record: RRID:CVCL_4782

      What is this?
      RRID:CVCL_4782
    Visit annotations in context

    Tags

    Annotators

    URL

    52.53.155.43/908848ce9212d2a4c8be94b24c71e399d1f50f03/Molecular Oncology - 2023 - Ito-html.html
  28. Jul 2023
  29. 52.53.155.43 52.53.155.43
    rational-design-and-development-of-selective-brd7-bromodomain-inhibitors-and-their-activity-in-prostate-cancer-html.html
    1
    1. scibot 26 Jul 2023
      RRID:CVCL_4782

      DOI: 10.26434/chemrxiv-2023-phgwf

      Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)

      Curator: @scibot

      SciCrunch record: RRID:CVCL_4782

      What is this?
      RRID:CVCL_4782
    Visit annotations in context

    Tags

    Annotators

    URL

    52.53.155.43/4e60af0f68b5fa24838946fe9ae1c8a74f7bd52b/rational-design-and-development-of-selective-brd7-bromodomain-inhibitors-and-their-activity-in-prostate-cancer-html.html
  30. Jun 2023
  31. www.sciencedirect.com www.sciencedirect.com
    Antiandrogen treatment induces stromal cell reprogramming to promote castration resistance in prostate cancer
    1
    1. scibot 23 Jun 2023
      CVCL_4782

      DOI: 10.1016/j.ccell.2023.05.016

      Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)

      Curator: @scibot

      SciCrunch record: RRID:CVCL_4782

      What is this?
      RRID:CVCL_4782
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S1535610823001836
  32. www.sciencedirect.com www.sciencedirect.com
    Minor intron splicing is critical for survival of lethal prostate cancer
    1
    1. scibot 09 Jun 2023
      RRID: CRL-3314

      DOI: 10.1016/j.molcel.2023.05.017

      Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)

      Curator: @sofiakhan13

      SciCrunch record: RRID:CVCL_4782

      What is this?
      RRID:CVCL_4782
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S1097276523003738
  33. May 2023
  34. www.biorxiv.org www.biorxiv.org
    The androgen receptor does not directly regulate the transcription of DNA damage response genes
    1
    1. scibot 19 May 2023
      RRID:CVCL_4782

      DOI: 10.1101/2023.05.13.540653

      Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)

      Curator: @jmitrevska

      SciCrunch record: RRID:CVCL_4782

      What is this?
      RRID:CVCL_4782
    Visit annotations in context

    Tags

    Annotators

    URL

    biorxiv.org/content/10.1101/2023.05.13.540653v1
  35. Mar 2023
  36. www.nature.com www.nature.com
    HOXB3 drives WNT-activation associated progression in castration-resistant prostate cancer
    1
    1. scibot 29 Mar 2023
      RRID:CVCL_4782

      DOI: 10.1038/s41419-023-05742-y

      Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)

      Curator: @scibot

      SciCrunch record: RRID:CVCL_4782

      What is this?
      RRID:CVCL_4782
    Visit annotations in context

    Tags

    Annotators

    URL

    nature.com/articles/s41419-023-05742-y
  37. Feb 2023
  38. aacrjournals.org aacrjournals.org
    Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
    1
    1. scibot 10 Feb 2023
      RRID:CVCL_4782

      DOI: 10.1158/0008-5472.CAN-22-1533

      Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)

      Curator: @scibot

      SciCrunch record: RRID:CVCL_4782

      What is this?
      RRID:CVCL_4782
    Visit annotations in context

    Tags

    Annotators

    URL

    aacrjournals.org/cancerres/article/83/2/219/715076/Plk1-Inhibitors-and-Abiraterone-Synergistically
  39. www.science.org www.science.org
    PI5P4Kα supports prostate cancer metabolism and exposes a survival vulnerability during androgen receptor inhibition
    1
    1. scibot 06 Feb 2023
      RRID: CRL-3314

      DOI: 10.1126/sciadv.ade8641

      Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)

      Curator: @bandrow

      SciCrunch record: RRID:CVCL_4782

      What is this?
      RRID:CVCL_4782
    Visit annotations in context

    Tags

    Annotators

    URL

    science.org/doi/10.1126/sciadv.ade8641
  40. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Optimization and characterization of a bone culture model to study prostate cancer bone metastasis
    1
    1. scibot 04 Feb 2023
      RRID:CVCL_4782

      DOI: 10.1158/1535-7163.MCT-21-0684

      Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)

      Curator: @evieth

      SciCrunch record: RRID:CVCL_4782

      What is this?
      RRID:CVCL_4782
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9357208/
  41. Aug 2022
  42. 52.53.155.43 52.53.155.43
    can-21-3822-html.html
    1
    1. scibot 27 Aug 2022
      RRID: CVCL_4782

      DOI: 10.1158/0008-5472.CAN-21-3822

      Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)

      Curator: @a5munoz

      SciCrunch record: RRID:CVCL_4782

      What is this?
      RRID:CVCL_4782
    Visit annotations in context

    Tags

    Annotators

    URL

    52.53.155.43/dd3eefda3af893731a099d04e9c9cf29063e7336/can-21-3822-html.html
  43. 52.53.155.43 52.53.155.43
    1360-html.html
    1
    1. scibot 27 Aug 2022
      RRID:CVCL_4782

      DOI: 10.1158/1535-7163.MCT-21-0684

      Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)

      Curator: @scibot

      SciCrunch record: RRID:CVCL_4782

      What is this?
      RRID:CVCL_4782
    Visit annotations in context

    Tags

    Annotators

    URL

    52.53.155.43/49d342e1bd5865d528f0b694cb2824f7aad4df9f/1360-html.html
  44. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    AR-V7 exhibits non-canonical mechanisms of nuclear import and chromatin engagement in castrate-resistant prostate cancer
    1
    1. scibot 26 Aug 2022
      RRID:CVCL_4782

      DOI: 10.7554/eLife.73396

      Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)

      Curator: @scibot

      SciCrunch record: RRID:CVCL_4782

      What is this?
      RRID:CVCL_4782
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9398446/
  45. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Assessment of Androgen Receptor splice variant-7 as a biomarker of clinical response in castration-sensitive prostate cancer
    1
    1. scibot 26 Aug 2022
      CVCL_4782

      DOI: 10.1158/1078-0432.CCR-22-0851

      Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)

      Curator: @scibot

      SciCrunch record: RRID:CVCL_4782

      What is this?
      RRID:CVCL_4782
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9378683/
  46. www.sciencedirect.com www.sciencedirect.com
    Air-liquid organotypic assays to investigate cellular crosstalk in the tumor microenvironment of cancer cells
    1
    1. scibot 22 Aug 2022
      RRID:CVCL_4782

      DOI: 10.1016/j.xpro.2022.101635

      Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)

      Curator: @scibot

      SciCrunch record: RRID:CVCL_4782

      What is this?
      RRID:CVCL_4782
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2666166722005159
  47. Jul 2022
  48. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    FcγRIIIa receptor interacts with androgen receptor and PIP5K1α to promote growth and metastasis of prostate cancer
    1
    1. scibot 12 Jul 2022
      RRID:CVCL_4782

      DOI: 10.1002/1878-0261.13166

      Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)

      Curator: @scibot

      SciCrunch record: RRID:CVCL_4782

      What is this?
      RRID:CVCL_4782
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9251882/
  49. May 2022
  50. www.sciencedirect.com www.sciencedirect.com
    The lactate-NAD+ axis activates cancer-associated fibroblasts by downregulating p62
    1
    1. scibot 11 May 2022
      RRID:CVCL_4782

      DOI: 10.1016/j.celrep.2022.110792

      Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)

      Curator: @scibot

      SciCrunch record: RRID:CVCL_4782

      What is this?
      RRID:CVCL_4782
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2211124722005599
  51. www.cell.com www.cell.com
    Systematic discovery of mutation-directed neo-protein-protein interactions in cancer
    1
    1. scibot 05 May 2022
      RRID:CVCL_4782

      DOI: 10.1016/j.cell.2022.04.014

      Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)

      Curator: @scibot

      SciCrunch record: RRID:CVCL_4782

      What is this?
      RRID:CVCL_4782
    Visit annotations in context

    Tags

    Annotators

    URL

    cell.com/cell/fulltext/S0092-8674(22)00461-5
  52. Apr 2022
  53. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    MIRO2 regulates prostate cancer cell growth via GCN1-dependent stress signaling
    1
    1. scibot 08 Apr 2022
      RRID:CVCL_4782

      DOI: 10.1158/1541-7786.MCR-21-0374

      Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)

      Curator: @scibot

      SciCrunch record: RRID:CVCL_4782

      What is this?
      RRID:CVCL_4782
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC8983529/
  54. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    PIP5K1α is Required for Promoting Tumor Progression in Castration-Resistant Prostate Cancer
    1
    1. scibot 07 Apr 2022
      RRID:CVCL_4782

      DOI: 10.3389/fcell.2022.798590

      Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)

      Curator: @scibot

      SciCrunch record: RRID:CVCL_4782

      What is this?
      RRID:CVCL_4782
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC8979106/
  55. Mar 2022
  56. www.sciencedirect.com www.sciencedirect.com
    Inhibiting 3βHSD1 to eliminate the oncogenic effects of progesterone in prostate cancer
    1
    1. scibot 18 Mar 2022
      ATCCCRL-3314

      DOI: 10.1016/j.xcrm.2022.100561

      Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)

      Curator: @sophiastull

      SciCrunch record: RRID:CVCL_4782

      What is this?
      RRID:CVCL_4782
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2666379122000684
  57. Nov 2021
  58. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    AXL cooperates with EGFR to mediate neutrophil elastase-induced migration of prostate cancer cells
    1
    1. scibot 16 Nov 2021
      RRID:CVCL_4782

      DOI: 10.1016/j.isci.2021.103270

      Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)

      Curator: @scibot

      SciCrunch record: RRID:CVCL_4782

      What is this?
      RRID:CVCL_4782
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC8567381/
  59. Aug 2021
  60. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    BRD9 is a critical regulator of androgen receptor signaling and prostate cancer progression
    1
    1. scibot 17 Aug 2021
      RRID:CVCL_4782

      DOI: 10.1158/0008-5472.CAN-20-1417

      Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)

      Curator: @evieth

      SciCrunch record: RRID:CVCL_4782

      What is this?
      RRID:CVCL_4782
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC8026650/
  61. www.sciencedirect.com www.sciencedirect.com
    CREB5 Promotes Resistance to Androgen-Receptor Antagonists and Androgen Deprivation in Prostate Cancer
    1
    1. scibot 01 Aug 2021
      RRID:CVCL_4782

      DOI: 10.1016/j.celrep.2019.10.068

      Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)

      Curator: @ethanbadger

      SciCrunch record: RRID:CVCL_4782

      What is this?
      RRID:CVCL_4782 RRIDCUR:Validated
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2211124719313828
  62. Apr 2021
  63. www.sciencedirect.com www.sciencedirect.com
    SETD2 Restricts Prostate Cancer Metastasis by Integrating EZH2 and AMPK Signaling Pathways
    1
    1. scibot 17 Apr 2021
      RRID:CVCL_4782

      DOI: 10.1016/j.ccell.2020.05.022

      Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)

      Curator: @Naa003

      SciCrunch record: RRID:CVCL_4782

      What is this?
      RRID:CVCL_4782 RRIDCUR:Validated
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S1535610820302725
  64. Feb 2021
  65. www.sciencedirect.com www.sciencedirect.com
    An acetyl-histone vulnerability in PI3K/AKT inhibition-resistant cancers is targetable by both BET and HDAC inhibitors
    1
    1. scibot 24 Feb 2021
      C4-2

      DOI: 10.1016/j.celrep.2021.108744

      Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)

      Curator: @Naa003

      SciCrunch record: RRID:CVCL_4782

      What is this?
      RRID:CVCL_4782 RRIDCUR:Missing
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2211124721000577
  66. Jan 2021
  67. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    CD117/c-kit defines a prostate CSC-like subpopulation driving progression and TKI resistance
    1
    1. scibot 20 Jan 2021
      RRID:CVCL_4782

      DOI: 10.1038/s41598-021-81126-6

      Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)

      Curator: @evieth

      SciCrunch record: RRID:CVCL_4782

      What is this?
      RRIDCUR:Validated RRID:CVCL_4782
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC7809150/
  68. Sep 2020
  69. febs.onlinelibrary.wiley.com febs.onlinelibrary.wiley.com
    FEBS Press
    1
    1. scibot 16 Sep 2020
      RRID:CVCL_4782

      DOI: 10.1002/1878-0261.12706

      Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)

      Curator: @Naa003

      SciCrunch record: RRID:CVCL_4782

      What is this?
      RRIDCUR:Validated RRID:CVCL_4782
    Visit annotations in context

    Tags

    Annotators

    URL

    febs.onlinelibrary.wiley.com/doi/10.1002/1878-0261.12706
  70. Aug 2020
  71. elifesciences.org elifesciences.org
    AR phosphorylation and CHK2 kinase activity regulates IR-stabilized AR–CHK2 interaction and prostate cancer survival
    1
    1. scibot 20 Aug 2020
      RRID:CVCL_4782

      DOI: 10.7554/eLife.51378

      Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)

      Curator: @evieth

      SciCrunch record: RRID:CVCL_4782

      What is this?
      RRID:CVCL_4782
    Visit annotations in context

    Tags

    Annotators

    URL

    elifesciences.org/articles/51378
  72. Jan 2020
  73. www.sciencedirect.com www.sciencedirect.com
    VISAGE Reveals a Targetable Mitotic Spindle Vulnerability in Cancer Cells
    1
    1. scibot 13 Jan 2020
      RRID:CVCL_4782

      DOI: 10.1016/j.cels.2019.05.009

      Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)

      Curator: @ethanbadger

      SciCrunch record: RRID:CVCL_4782

      What is this?

      RRID:CVCL_4782 RRIDCUR:Validated
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2405471219301905
  74. www.sciencedirect.com www.sciencedirect.com
    ROS and Oxidative Stress Are Elevated in Mitosis during Asynchronous Cell Cycle Progression and Are Exacerbated by Mitotic Arrest
    1
    1. scibot 13 Jan 2020
      RRID:CVCL_4782

      DOI: 10.1016/j.cels.2019.01.005

      Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)

      Curator: @ethanbadger

      SciCrunch record: RRID:CVCL_4782

      What is this?

      RRID:CVCL_4782 RRIDCUR:Validated
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S240547121930033X
  75. www.sciencedirect.com www.sciencedirect.com
    Preclinical study using androgen receptor (AR) degradation enhancer to increase radiotherapy efficacy via targeting radiation-increased AR to better suppress prostate cancer progression
    1
    1. scibot 13 Jan 2020
      RRID:CVCL_4782

      DOI: 10.1016/j.ebiom.2018.12.050

      Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)

      Curator: @ethanbadger

      SciCrunch record: RRID:CVCL_4782

      What is this?

      RRID:CVCL_4782 RRIDCUR:Validated
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2352396418306273